| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $27.8M | -5.7% |
| SG&A Expense | $15.3M | +24.8% |
| Operating Income | -$43.0M | -3.3% |
| Interest Expense | $4.2M | +219.5% |
| Pre-tax Income | -$44.3M | -5.5% |
| Income Tax | -$1.4M | -17.3% |
| Net Income | -$42.9M | -5.1% |
| EPS (Basic) | -$1.39 | +2.8% |
| EPS (Diluted) | -$1.39 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $56.6M | -23.4% |
| Current Assets | $59.1M | -22.8% |
| Total Assets | $59.4M | -22.9% |
| Current Liabilities | $13.6M | +38.8% |
| Total Liabilities | $33.3M | +0.8% |
| Stockholders' Equity | $26.1M | -40.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$33.6M | -30.8% |
| Financing Cash Flow | $16.4M | -52.2% |
| +2.8% |